[go: up one dir, main page]

ZA976846B - The use of (meth) acrylic acid copolymers for increasing mucosal permeability - Google Patents

The use of (meth) acrylic acid copolymers for increasing mucosal permeability

Info

Publication number
ZA976846B
ZA976846B ZA976846A ZA976846A ZA976846B ZA 976846 B ZA976846 B ZA 976846B ZA 976846 A ZA976846 A ZA 976846A ZA 976846 A ZA976846 A ZA 976846A ZA 976846 B ZA976846 B ZA 976846B
Authority
ZA
South Africa
Prior art keywords
meth
acrylic acid
acid copolymers
mucosal permeability
increasing mucosal
Prior art date
Application number
ZA976846A
Other languages
English (en)
Inventor
Karl Kolter
Thomas Subkowski
Martin Raditsch
Volker Schehlmann
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA976846B publication Critical patent/ZA976846B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
ZA976846A 1996-08-01 1997-07-31 The use of (meth) acrylic acid copolymers for increasing mucosal permeability ZA976846B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19631084A DE19631084A1 (de) 1996-08-01 1996-08-01 Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut

Publications (1)

Publication Number Publication Date
ZA976846B true ZA976846B (en) 1999-02-01

Family

ID=7801501

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976846A ZA976846B (en) 1996-08-01 1997-07-31 The use of (meth) acrylic acid copolymers for increasing mucosal permeability

Country Status (11)

Country Link
US (1) US6555124B1 (xx)
EP (1) EP0918542B1 (xx)
JP (1) JP2000515159A (xx)
KR (1) KR20000029736A (xx)
CN (1) CN1182872C (xx)
AU (1) AU3769197A (xx)
BR (1) BR9710889A (xx)
DE (2) DE19631084A1 (xx)
ES (1) ES2221060T3 (xx)
WO (1) WO1998005360A2 (xx)
ZA (1) ZA976846B (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169318A1 (de) * 1999-04-09 2002-01-09 Basf Aktiengesellschaft Prodrugs von thrombininhibitoren
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
BR0207932A (pt) * 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Composições farmacêuticas de sabor mascarado
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
WO2002087645A1 (en) * 2001-05-01 2002-11-07 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
TWI355276B (en) * 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
LT5465B (lt) 2006-03-29 2008-01-25 Bugajec, Evgenij Koaksialinis uždegimo kabelis
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
EP2387394B1 (en) 2009-01-14 2018-05-02 Corium International, Inc. Transdermal administration of tamsulosin
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
WO2011115974A1 (en) 2010-03-15 2011-09-22 Indiana University Research And Technology Corporation Engineered lumenized vascular networks and support matrix
JP5877935B2 (ja) 2012-10-17 2016-03-08 メチレーション・サイエンシーズ・インターナショナル・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティＭｅｔｈｙｌａｔｉｏｎ Ｓｃｉｅｎｃｅｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｓｒｌ Ｓ−アデノシルメチオニンおよび没食子酸エステルを含む組成物
WO2019105519A1 (en) 2017-12-03 2019-06-06 Abd Elaal Nasser Kamal Tranexamic acid coated or eluted uterine balloon and co-attached cervical shutter in the management of postpartum haemorrhage
US20230355689A1 (en) 2019-12-27 2023-11-09 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
TW202140051A (zh) 2020-01-17 2021-11-01 美商艾弗洛生物科技股份有限公司 具有改善的崩散譜之固體劑型
WO2021212000A1 (en) 2020-04-17 2021-10-21 Evelo Biosciences, Inc. Solid dosage forms with improved disintegration profiles
EP4213814A1 (en) 2020-09-18 2023-07-26 Evelo Biosciences, Inc. Solid dosage forms of bacteria
WO2022061123A1 (en) 2020-09-21 2022-03-24 Evelo Biosciences, Inc. Solid dosage forms with improved disintegration profiles
TW202233213A (zh) 2020-10-29 2022-09-01 美商艾弗洛生物科技股份有限公司 包含螺旋藻組分之組成物
JP2024501481A (ja) 2020-12-14 2024-01-12 エヴェロ バイオサイエンシズ，インコーポレーテッド 細胞外小胞調製物
WO2022140396A1 (en) 2020-12-22 2022-06-30 Evelo Biosciences, Inc. Compositions comprising animal hemoglobin
EP4284400A1 (en) 2021-01-26 2023-12-06 Evelo Biosciences, Inc. Prevotella extracellular vesicle preparations
EP4297762A1 (en) 2021-02-26 2024-01-03 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187578A1 (en) 2021-03-05 2022-09-09 Evelo Biosciences, Inc. Solid dosage forms
TW202304415A (zh) 2021-04-08 2023-02-01 美商艾弗洛生物科技股份有限公司 含有細菌的藥物製劑
WO2022221183A1 (en) 2021-04-12 2022-10-20 Evelo Biosciences, Inc. Fournierella extracellular vesicle preparations
WO2022251166A2 (en) 2021-05-25 2022-12-01 Evelo Biosciences, Inc. Bacterial compositions comprising soy hemoglobin
US20250114411A1 (en) 2021-09-24 2025-04-10 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
WO2023114295A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Veillonella parvula bacteria extracellular vesicle preparations
WO2023114296A2 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Extracellular vesicle preparations
WO2023114300A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Fournierella massiliensis bacteria extracellular vesicle preparations
WO2023146843A1 (en) 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023183396A1 (en) 2022-03-22 2023-09-28 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023200837A1 (en) 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023239728A1 (en) 2022-06-07 2023-12-14 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles
WO2024102226A1 (en) 2022-10-14 2024-05-16 Evelo Biosciences, Inc. Methods for assaying drug substances and drug products by using cell lines with nf-kb- inducible reporter genes
AU2024274445A1 (en) 2023-05-15 2025-11-27 Bonafide Health, Llc Sleep-improving compositions and methods of use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003991A (en) 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
GB1596166A (en) 1977-11-14 1981-08-19 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical compositions
CH637017A5 (en) * 1977-11-21 1983-07-15 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of pharmaceutical active compounds having a depot effect
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
CA1306949C (en) 1985-08-26 1992-09-01 Nalinkant Chunilal Damani Taste masking compositions
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
JPH0347134A (ja) * 1989-03-08 1991-02-28 Hoechst Japan Ltd ヒドロゲル製剤およびキセロゲル製剤の製造法
CA2065311C (en) 1989-09-08 2000-01-11 Chia-Ming Chiang Solid matrix system for transdermal drug delivery
DE3930733A1 (de) * 1989-09-14 1991-03-28 Roehm Gmbh Verfahren zur herstellung eines komplexierten arzneimittels
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
DK0518468T3 (da) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatoninholdige sammensætninger
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
AT403988B (de) 1994-05-18 1998-07-27 Lannacher Heilmittel Festes orales retardpräparat
DE19631085A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut

Also Published As

Publication number Publication date
DE59711600D1 (de) 2004-06-09
WO1998005360A2 (de) 1998-02-12
DE19631084A1 (de) 1998-02-05
WO1998005360A3 (de) 1998-05-07
EP0918542A2 (de) 1999-06-02
JP2000515159A (ja) 2000-11-14
ES2221060T3 (es) 2004-12-16
KR20000029736A (ko) 2000-05-25
CN1182872C (zh) 2005-01-05
CN1226834A (zh) 1999-08-25
EP0918542B1 (de) 2004-05-06
AU3769197A (en) 1998-02-25
BR9710889A (pt) 1999-08-17
US6555124B1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
ZA976846B (en) The use of (meth) acrylic acid copolymers for increasing mucosal permeability
SG77590A1 (en) Purification of acrylic acid and methacrylic acid
GB9404962D0 (en) Light brick
GB9500327D0 (en) alpha - pyrimidinyl acrylic acid derivatives
AU6293098A (en) Home-brew device
AU3494295A (en) Dibromostyrene-glycidyl (meth)acrylate copolymers
GB9703466D0 (en) Clamp
EP0942018A4 (en) (METH) ACRYLESTER COPOLYMERS AND METHOD FOR THE PRODUCTION THEREOF
ZA9810592B (en) Acrylic monomers
GB9602037D0 (en) Desulphurisation
GB9602036D0 (en) Smelting
GB2318309B (en) Desulphurisation
GB9611920D0 (en) Acrylic sheet
GB2323890B (en) Clamp
MD950F1 (en) Clamp
GB9724883D0 (en) Universal tube clamp
GB9812079D0 (en) Acrylic esters
TW353936U (en) Self-clamping tweezers
AUPO409496A0 (en) Brick clip
AU132751S (en) Mosaic brick
AU132750S (en) Mosaic brick
AU132753S (en) Mosaic brick
AU132755S (en) Mosaic brick
AU132758S (en) Mosaic brick
AU132759S (en) Mosaic brick